{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T08:17:06Z","timestamp":1772698626302,"version":"3.50.1"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,3,4]]},"DOI":"10.7759\/cureus.104691","type":"journal-article","created":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T07:35:04Z","timestamp":1772696104000},"source":"Crossref","is-referenced-by-count":0,"title":["Unusual Nasopharyngeal Localization of Chronic Lymphocytic Leukemia: A Case Report"],"prefix":"10.7759","author":[{"given":"Monsif","family":"FADI","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Said","family":"Anajar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hafsa","family":"Chahdi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatima Azzahra","family":"Lahlou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nouama","family":"Bouanani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-024-05854-1","article-title":"Extramedullary and extranodal manifestations in chronic lymphocytic leukemia - an update","volume":"103","author":"Robak T","year":"2024","unstructured":"Robak T, Pu\u0142a A, Braun M, Robak E. Extramedullary and extranodal manifestations in chronic lymphocytic leukemia - an update. Ann Hematol. 2024, 103:3369-83. 10.1007\/s00277-024-05854-1","journal-title":"Ann Hematol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.5858\/2007-131-383-SLPIEL","article-title":"Small lymphoid proliferations in extranodal locations","volume":"131","author":"Rao DS","year":"2007","unstructured":"Rao DS, Said JW. Small lymphoid proliferations in extranodal locations. Arch Pathol Lab Med. 2007, 131:383-96. 10.5858\/2007-131-383-SLPIEL","journal-title":"Arch Pathol Lab Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1186\/1472-6815-9-11","article-title":"Primary Nasopharyngeal non-Hodgkin lymphomas: a retrospective review of 26 Moroccan patients","volume":"9","author":"Allam W","year":"2009","unstructured":"Allam W, Ismaili N, Elmajjaoui S, Elgueddari BK, Ismaili M, Errihani H. Primary Nasopharyngeal non-Hodgkin lymphomas: a retrospective review of 26 Moroccan patients. BMC Ear Nose Throat Disord. 2009, 9:11. 10.1186\/1472-6815-9-11","journal-title":"BMC Ear Nose Throat Disord"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200012283432602","article-title":"Genomic aberrations and survival in chronic lymphocytic leukemia","volume":"343","author":"D\u00f6hner H","year":"2000","unstructured":"D\u00f6hner H, Stilgenbauer S, Benner A, et al.. Genomic aberrations and survival in chronic lymphocytic leukemia. N Engl J Med. 2000, 343:1910-6. 10.1056\/NEJM200012283432602","journal-title":"N Engl J Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V94.6.1848","article-title":"Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia","volume":"94","author":"Hamblin TJ","year":"1999","unstructured":"Hamblin TJ, Davis Z, Gardiner A, Oscier DG, Stevenson FK. Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood. 1999, 94:1848-54. 10.1182\/blood.V94.6.1848","journal-title":"Blood"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2016.96","article-title":"Chronic lymphocytic leukaemia","volume":"3","author":"Kipps TJ","year":"2017","unstructured":"Kipps TJ, Stevenson FK, Wu CJ, et al.. Chronic lymphocytic leukaemia. Nat Rev Dis Primers. 2017, 3:16096. 10.1038\/nrdp.2016.96","journal-title":"Nat Rev Dis Primers"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.27.8762","article-title":"TP53 mutation and survival in chronic lymphocytic leukemia","volume":"28","author":"Zenz T","year":"2010","unstructured":"Zenz T, Eichhorst B, Busch R, et al.. TP53 mutation and survival in chronic lymphocytic leukemia. J Clin Oncol. 2010, 28:4473-9. 10.1200\/JCO.2009.27.8762","journal-title":"J Clin Oncol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)30422-7","article-title":"Chronic lymphocytic leukaemia","volume":"391","author":"Hallek M","year":"2018","unstructured":"Hallek M, Shanafelt TD, Eichhorst B. Chronic lymphocytic leukaemia. Lancet Lond Engl. 2018, 391:1524-37. 10.1016\/S0140-6736(18)30422-7","journal-title":"Lancet Lond Engl"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V94.2.448","article-title":"Clinical characteristics and outcome of young chronic lymphocytic leukemia patients: a single institution study of 204 cases","volume":"94","author":"Mauro FR","year":"1999","unstructured":"Mauro FR, Foa R, Giannarelli D, et al.. Clinical characteristics and outcome of young chronic lymphocytic leukemia patients: a single institution study of 204 cases. Blood. 1999, 94:448-54. 10.1182\/blood.V94.2.448","journal-title":"Blood"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcancer.2013.08.011","article-title":"The microenvironment in chronic lymphocytic leukemia (CLL) and other B cell malignancies: insight into disease biology and new targeted therapies","volume":"24","author":"Burger JA","year":"2014","unstructured":"Burger JA, Gribben JG. The microenvironment in chronic lymphocytic leukemia (CLL) and other B cell malignancies: insight into disease biology and new targeted therapies. Semin Cancer Biol. 2014, 24:71-81. 10.1016\/j.semcancer.2013.08.011","journal-title":"Semin Cancer Biol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.15.4393","article-title":"Novel insights in chronic lymphocytic leukemia: are we getting closer to understanding the pathogenesis of the disease?","volume":"26","author":"Caligaris-Cappio F","year":"2008","unstructured":"Caligaris-Cappio F, Ghia P. Novel insights in chronic lymphocytic leukemia: are we getting closer to understanding the pathogenesis of the disease?. J Clin Oncol. 2008, 26:4497-503. 10.1200\/JCO.2007.15.4393","journal-title":"J Clin Oncol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.39.2688","article-title":"Bendamustine in combination with rituximab for previously untreated patients with chronic lymphocytic leukemia: a multicenter phase II trial of the German Chronic Lymphocytic Leukemia Study Group","volume":"30","author":"Fischer K","year":"2012","unstructured":"Fischer K, Cramer P, Busch R, et al.. Bendamustine in combination with rituximab for previously untreated patients with chronic lymphocytic leukemia: a multicenter phase II trial of the German Chronic Lymphocytic Leukemia Study Group. J Clin Oncol. 2012, 30:3209-16. 10.1200\/JCO.2011.39.2688","journal-title":"J Clin Oncol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(16)30051-1","article-title":"First-line chemoimmunotherapy with bendamustine and rituximab versus fludarabine, cyclophosphamide, and rituximab in patients with advanced chronic lymphocytic leukaemia (CLL10): an international, open-label, randomised, phase 3, non-inferiority trial","volume":"17","author":"Eichhorst B","year":"2016","unstructured":"Eichhorst B, Fink A-M, Bahlo J. First-line chemoimmunotherapy with bendamustine and rituximab versus fludarabine, cyclophosphamide, and rituximab in patients with advanced chronic lymphocytic leukaemia (CLL10): an international, open-label, randomised, phase 3, non-inferiority trial. Lancet Oncol. 2016, 17:928-42. 10.1016\/S1470-2045(16)30051-1","journal-title":"Lancet Oncol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1313984","article-title":"Obinutuzumab plus chlorambucil in patients with CLL and coexisting conditions","volume":"370","author":"Goede V","year":"2014","unstructured":"Goede V, Fischer K, Busch R, et al.. Obinutuzumab plus chlorambucil in patients with CLL and coexisting conditions. N Engl J Med. 2014, 370:1101-10. 10.1056\/NEJMoa1313984","journal-title":"N Engl J Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/463131-unusual-nasopharyngeal-localization-of-chronic-lymphocytic-leukemia-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T07:35:05Z","timestamp":1772696105000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/463131-unusual-nasopharyngeal-localization-of-chronic-lymphocytic-leukemia-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,4]]},"references-count":14,"URL":"https:\/\/doi.org\/10.7759\/cureus.104691","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3,4]]}}}